2. NORMAL MENSTRUAL PHASES
NAME OF THE PHASE AVERAGE DURATION RANGE
MENSES 5 DAYS 1 – 7 DAYS
PROLIFERATIVE PHASE 10 DAYS 9 – 20 DAYS
SECRETORY PHASE 14 DAYS 14 DAYS (CONSTANT)
MORPHOLOGICAL
DATE
CHRONOLOGICAL
DATE
VS
3. GLAND STROMAL RATIO (UNDER 10X)
1:1 MORE GLANDS MORE STROMA
NORMAL CYCLING
ENDOMETRIUM
LATE SECRETORY ENDOMETRIA DECIDUA
DYSFUNCTIONAL UTERINE
BLEEDING
MENSTRUATION ATROPHY
INFERTILITY ENDOMETRIAL HYPERPLASIA
CARCINOMAS
MONOPHASIC SPINDLE CELL
PROLIFERATIONS
- SMOOTH MUSCLE
NEOPLASMS
- ENDOMETRIAL STROMAL
NEOPLASM
- SPINDLED EPITHELIAL
NEOPLASM
- UTERINE SARCOMAS
4. NORMAL PROLIFERATIVE ENDOMETRIUM
• EPITHELIUM
• PSEUDOSTRATIFIED
• MITOTICALLY ACTIVE
• ELONGATED CELLS
• STRATUM FUNCTIONALIS
• NON BRANCHING
• NON BUDDING
• SIMILAR SHAPED & EVENLY
DISTRIBUTED GLANDS
• STROMA
• MITOTICALLY ACTIVE
• MONOMORPHOUS
• UNDIFFERENTIATED STROMAL
CELLS
• SCANT CYTOPLASM
• INDISTINCT CELL MARGINS
• VASCULATURE
• UNIFORM, ARBORIZING AND
THIN WALLED VESSELS
7. INTERVAL ENDOMETRIUM
• GLANDS
• COILED
• <50% OF EPITHELIAL CELLS WITH SUB NUCLEAR VACUOLATION
• EVIDENCE OF SECRETION
• EVIDENCE OF OVULATION
• APPEARANCE OF DISTINCTIVE NUCLEOLAR CHANNEL SYSTEM
• POD 1 & 2 ALSO SHOW THESE FINDINGS
8. EARLY SECRETORY PHASE (POD 2 – 5)
• GLANDS
• COILED
• >50% CELLS WITH LARGE
SUBNUCLEAR CYTOPLASMIC
VACUOLES
• MITOTIC FIGURES PRESENT
• STROMA
• NON PREDECIDUATED
• CLINICOPATH CORRELATION
• H/O MID CYCLE SPOTTING
• MITTELSCHMERZ
18. SECRETORY GLAND
VACUOLATED
POD 2
UNIFORM SNV
>50%
NUCLEAR
PSEUDOSTRATIFICATION
MITOTIC
FIGURES
POD 3 POD 4
LUMINAL
POSITION OF
VACUOLES
RARE MITOTIC
FIGURES
POD 5
SECRETIONS
VACUOLES
INFREQUENT
19. SECRETORY NON VACUOLATED
NON DECIDUALISED STROMA
POD 6
PROMINENT
SECRETION
POD 7
STROMAL
EDEMA +
POD 8
STROMAL
EDEMA +++
PRE
DECIDUAL
LATE
SECRETORY,
MENSTRUAL
20. SECRETORY NON VACUOLATED
NO CRUMBLING OF STROMA
POD 9
SPIRAL
ARTERIES +
POD 10
PERIARTERIAL
CUFFS +
POD 11
PREDECIDUA
ISLANDS
POD 12
COALESCENCE
OF ISLANDS
POD 13
STROMAL
GRANULOCYTES
+
POD 14
RBC IN
STROMA
CRUMBLED
STROMA
MENSTRUATION
23. ESTROGENS
• PROMOTE THE GROWTH OF A NON SECRETORY ENDOMETRIUM
• ENDOGENOUS – CHRONIC ANOVULATION
• EXOGENOUS – HORMONE REPLACEMENT THERAPY
• PREDISPOSES TO
• ENDOMETRIAL HYPERPLASIA
• ENDOMETRIAL CARCINOMA (2-15 FOLD INCREASED RISK) – WELL
DIFFERENTIATED AND SUPERFICIAL WITH GOOD PROGNOSIS
24. PROGESTATIONAL AGENTS
• THERAPEUTIC & CONTRACEPTIVE PURPOSES
• CHANGES SEEN MAINLY IN STROMA – PSEUDODECIDUAL CHANGES
• GLANDS
• SMALL
• WIDELY SEPARATED
• ATROPHIC
• TAKES WEEKS TO RETURN TO NORMAL PATTERN ON
DISCONTINUATION
• ARIAS STELLA REACTION
25. ARIAS STELLA REACTION
• CAN BE FOCAL, EXTRA
ENDOMETRIAL
• GLANDS
• HYPERSECRETORY
• LARGE CELLS
• CYTOPLASM – EOSINOPHILIC,
ABUNDANT
• NUCLEI – IRREGULAR LARGE,
SMUDGED, PLEOMORPHIC
26. SYNTHETIC PROGESTERONE RECEPTOR
MODULATORS
• INDICATION
• ENDOMETRIOSIS
• UTERINE LEIOMYOMAS
• GLANDS
• ATROPHIC OR INACTIVE EPITHELIUM
• CYSTIC DILATED
• DYSSYNCHRONY BETWEEN GLANDS AND STROMA
• THICK WALLED CORDED VESSELS CLOSE TO SURFACE EPITHELIUM
• CILIARY METAPLASIA IS COMMON
27. TAMOXIFEN
• SYNTHETIC ANTI-ESTROGEN
• INDICATION : PROPHYLAXIS OF BREAST CARCINOMA
• PARADOXICAL ESTROGENIC EFFECT IN THE ABSENCE OF OVARIAN
OESTROGEN
• CAUSES
• HYPERPLASIAS
• POLYPS
• MALIGNANT TUMOURS
• ENDOMETRIAL CARCINOMA WITH BAD PROGNOSIS
28. GESTATIONAL ENDOMETRIUM
• EARLY
• COINCIDENCE OF
• GLANDULAR LUMINAL SECRETION
• PRE DECIDUALISATION
• STROMAL EDEMA
• FULLY DEVELOPED
• GLANDS
• FLATTENED OR CUBOIDAL LINING
• NUCLEAR INCLUSIONS – BIOTIN
ACCUMULATION
• SURROUNDED BY SHEETS OF
DECIDUA
• ASSOCIATED FINDINGS –
CHORIONIC VILLI, PLACENTA,
FETAL PARTS ETC
30. ACUTE ENDOMETRITIS
• INFLAMMATORY CELLS ARE
NORMALLY PRESENT ON DAYS
26,27,28
• ACUTE ENDOMETRITIS
• ABORTION
• POSTPARTUM STATE
• INSTRUMENTATION
• INFILTRATION & DESTRUCTION
OF GLANDS BY PMNs
32. ACTINOMYCES
• CENTRAL BRANCHING
FILAMENTS
• DIPHETHEROID FORMS
• DEVELOPS FOLLOWING
INSERTION OF IUD
HEMATOMETRA
• CERVICAL OCCLUSION
• MICROSCOPY
• DISAPPEARANCE OF MUCOSA
• LIPID CONTAINING HISTIOCYTIC
CELSS –
XANTHOGRANULOMATOUS
ENDOMETRITIS
• YELLOWISH-BROWN
CYTOPLASMIC PIGMENT –
CEROID CONTAINING HISTIOCYTIC
GRANULOMA
33. ENDOMETRIAL TUBERCULOSIS
• SYMPTOMS
• MENSTRUAL ABNORMALITY
• INFERTILITY
• AFB IN TUBERCLES/CULTURE
• GRANULOMAS CONCENTRATE IN SUPERFICIAL LAYERS
• TAKE EM BX DURING LATE SECRETORY PHASE
34. OTHERS
• CHLAMYDIA – IHC OF ANTIGENS OR PCR, PLASMA CELLS
• VIRAL INFECTIONS – CMV, HPV – GRANULOMATOUS
• COCCIDIODOMYCOSIS – FROM LUNG INFECTION
• POSTOPERATIVE GRANULOMAS – ENDOMETRIAL ABLATION
• SARCOIDOSIS
• GRANULOMATOUS REACTION SPREADS TO MYOMETRIUM
35. HOW TO AVOID OVERDIAGNOSIS?
• ABNORMAL CYCLIC PATTERN
• FOCAL MONONUCLEAR INFILTRATE
• INFLAMMATORY CELLS IN THE
GLANDULAR LUMINA
• DENSE STROMA
• A STELLATE STROMAL PATTERN OF
PROLIFERATION
• FOCI OF NECROSIS OR CALCIFICATION
36. METAPLASIA - SQUAMOUS
• MOST COMMON – PRE MENOPAUSAL, PCOS
• FRANK KERATINIZATION – ICTHYOSIS UTERI
• NON KERATINISED SQUAMOID CELLS
• DIFFUSE – ADENOACANTHOSIS
• AGGREGATES - MORULES
• MORULAR METAPLASIA
• FUNCTIONALY INERT
• NO SEX HORMONE RECEPTORS
• LOW PROLIFERATION RATE
• CDX2 – INTESTINAL TRANSCRIPTION FACTOR
+VE
37. METAPLASIA – CILIATED (TUBAL)
• SCATTERED CILIATED CELLS ARE
NORMAL IN THE ENDOMETRIUM
• MARKEDLY INCREASED – METAPLASIA
• COMMON IN ATROPHIC
ENDOMETRIUM
• NOT A SIGNIFICANT RISK FACTOR FOR
ADENO CARCINOMA
38. METAPLASIA - PAPILLARY
• SYNCTITIAL TO PAPILLARY
AGGREGATES OF EOSINOPHILIC
CELLS
• ENDOMETRIAL BREAKDOWN
39. MUCINOUS METAPLASIA
• MORPHOLOGICALLY,
HISTOCHEMICALLY &
ULTRASTRUCTURALLY SIMILAR TO
ENDOCERVICAL MUCOSA
• COMMON IN ENDOMETRIAL
POLYPS
EOSINOPHILIC METAPLASIA
• CELLS WITH ABUNDANT
EOSINOPHILIC CYTOPLASM
HOBNAIL & CLEAR CELL METAPLASIA
• EPITHELIUM – CLEAR, TALL CELLS
WITH APICALLY LOCATED NUCLEI
40. ADENOMYOSIS
• PRESENCE OF ISLANDS OF
ENDOMETRIAL GLANDS AND
STROMA DEEP WITHIN THE
MYOMETRIUM
• NON FUNCTIONAL – BASAL
LAYER OF ENDOMETRIUM
• LESS PROLIFERATIVE RATE
• FOUND IN PROLIFERATIVE
PHASE
ENDOMETRIOSIS
• OCCURRENCE OF
ENDOMETRIAL TISSUE OUTSIDE
THE UTERUS
• FUNCTIONAL LAYERS OF THE
ENDOMETRIUM
• MORE PROLIFERATIVE RATE
• PHASE CHANGES OCCORDING
TO CYCLE
41. ADENOMYOSIS & ENDOMETRIOSIS
THEORIES
• CONGENITAL MULLERIAN OR
WOLFFIAN RESTS
• IMPLANTATION OF
ENDOMETRIUM
• LYMPHATIC OR
HEMATOGENOUS SPREAD
• SEROSAL METAPLASIA
SYMPTOMS
• PELVIC PAIN – VARIES WITH THE
MENSTRUAL PERIOD
• INFERTILITY
• RUPTURE AT THE TIME OF
PREGNANCY
43. ENDOMETRIOSIS GROSS
• BLUISH CYSTIC NODULES
SURROUNDED BY FIBROSIS
• MULTIPLE POLYPOIDAL MASSES
– ENDOMETRIOTIC POLYPOSIS
OVARIES
UTERINE
LIGAMENT
RECTOVAGINAL
SEPTUM
CUL DE SAC
PELVIC PERITONEUM
LARGE AND SMALL BOWEL AND
APPENDIX,
MUCOSA -CERVIX, VAGINA, & FALLOPIAN
TUBES
LAPAROTOMY SCARS
44. MICROSCOPY - ADENOMYOSIS
• ENDOMETRIAL GLANDS &
STROMA ARE SEEN IN THE
MYOMETRIUM AT A DISTANCE
OF AT LEAST OF 1 LOW POWER
(10X) FIELD FROM THE EM-MM
JUNCTION
• ALWAYS IN PROLIFERATIVE
PHASE
• STROMA PREDOMINANT –
STROMAL ADENOMYOSIS
45. MICROSCOPY - ENDOMETRIOSIS
• ENDOMETRIAL GLANDS AND
STROMA IN DENSE FIBROUS
MASS WITH FRESH AND OLD
HEMORRHAGE
• STROMAL COMPONENT –
SMOOTH MUSCLE METAPLASIA
47. WEAKLY PROLIFERATIVE ENDOMETRIUM
• TUBULAR GLANDS – CELLS
WITH PSEUDOSTRATIFIED
NUCLEI
• MITOTIC FIGURES – ABSENT
• COMMON & NORMAL
PATTERN
• PERIMENOPAUSAL
• POSTMENOPAUSAL
48. DISORDERLY PROLIFERATIVE ENDOMETRIUM
• ABSENCE OF UNIFORM GLANDULAR
DEVELOPMENT
• DYSSYNCHRONOUS GROWTH OF THE
FUNCTIONALIS
• NORMAL G:S RATIO
• IDENTICAL TO LATE PROLIFERATIVE
PHASE
• NORMAL IN PERIMENARCHAL AND
PERIMENOPAUSAL AGE GROUP
• ANOVULATORY CYCLES
• EXOGENOUS ESTROGEN THERAPY
49. ENDOMETRIAL HYPERPLASIA
• PROLIFERATING
ENDOMETRIUM – GLANDULAR
CROWDING
• INCREASED GLAND STROMAL
RATIO = 2:1 OR 3:1
• CLASSIFICATION (WHO 2014)
• ENDOMETRIAL HYPERPLASIA
WITHOUT ATYPIA
• ATYPICAL HYPERPLASIA
50. HYPERPLASIA WITHOUT ATYPIA
• GLANDS
• CYSTIC DILATION
• MINIMAL BUDDING
• LINING EPITHELIUM – NORMAL
LP
• NO CYTOLOGICAL ATYPIA
• STROMA
• COMPRESSED